TP53 and neoplasm: Disruption of TP53, one of the most prominent tumour suppressor genes, explains the chemorefractory phenotype of RT; on the other hand, cell-cycle deregulation by CDKN2A deletion and MYC deregulation may result in the progressive biology of RT [8].